Navigation

CG79 Rheumatoid arthritis: full guideline

A correction has been made to the guideline. Recommendation R30.has been amended to remove text that stated an incorrect dose of etoricoxib for rheumatoid arthritis patients. The recommendation now reads: When offering treatment with an oral NSAID/COX-2 inhibitor, the first choice should be either a standard NSAID or a COX-2 inhibitor. In either case, these should be co‑prescribed with a proton pump inhibitor (PPI), choosing the one with the lowest acquisition cost.

Note that recommendations R29 - R32 are adapted from ‘Osteoarthritis:  the care and management of osteoarthritis in adults’ (NICE clinical guideline 59). These recommendations form part of  the Rheumatoid Arthritis clinical guideline update of the rheumatoid arthritis aspects of ‘Guidance on the use of cyclo-oxygenase (Cox)  II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis’ (NICE technology appraisal guidance 27).

This page was last updated: 23 January 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.